Targeting Macromolecules to CNS and Other Hard-to-Treat Organs Using Lectin-Mediated Delivery
Open Access
- 1 February 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (3) , 971
Abstract
The greatest challenges for therapeutic efficacy of many macromolecular drugs that act on intracellular are delivery to key organs and tissues and delivery into cells and subcellular compartments. Transport of drugs into critical cells associated with disease, including those in organs protected by restrictive biological barriers such as central nervous system (CNS), bone, and eye remains a significant hurdle to drug efficacy and impacts commercial risk and incentives for drug development for many diseases. These limitations expose a significant need for the development of novel strategies for macromolecule delivery. RTB lectin is the non-toxic carbohydrate-binding subunit B of ricin toxin with high affinity for galactose/galactosamine-containing glycolipids and glycoproteins common on human cell surfaces. RTB mediates endocytic uptake into mammalian cells by multiple routes exploiting both adsorptive-mediated and receptor-mediated mechanisms. In vivo biodistribution studies in lysosomal storage disease models provide evidence for the theory that the RTB-lectin transports corrective doses of enzymes across the blood–brain barrier to treat CNS pathologies. These results encompass significant implications for protein-based therapeutic approaches to address lysosomal and other diseases having strong CNS involvement.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (2R44NS084565-02, 2R44NS083230-02A1, 1R44NS102086-01)
This publication has 73 references indexed in Scilit:
- Ricin Crosses Polarized Human Intestinal Cells and Intestines of Ricin-Gavaged Mice without Evident Damage and Then Disseminates to Mouse KidneysPLOS ONE, 2013
- Identification of the Galactose Binding Domain of the Adeno-Associated Virus Serotype 9 CapsidJournal of Virology, 2012
- Uptake of ricinB-quantum dot nanoparticles by a macropinocytosis-like mechanismJournal of Nanobiotechnology, 2012
- Construction of an artificial cell membrane anchor using DARC as a fitting for artificial extracellular functionalities of eukaryotic cellsJournal of Nanobiotechnology, 2012
- Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)Vaccine, 2011
- Clathrin-independent endocytosis: mechanisms and functionCurrent Opinion in Cell Biology, 2011
- Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cellsJournal of Cell Biology, 2010
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentNature Biotechnology, 2008
- Immune response hinders therapy for lysosomal storage diseasesJournal of Clinical Investigation, 2008
- Characterization of a Novel High-Affinity Monoclonal Immunoglobulin G Antibody against the Ricin B SubunitInfection and Immunity, 2006